Severe Aortic Stenosis: Stratifying Patients for Lifetime Management
Published: 12 April 2022
In this symposium, part of the Transcatheter Interventions Online 2022, the faculty consider when to use a surgery or TAVI-first approach, summarise clinical evidence to date and assess possible management scenarios by way of clinical cases.
The symposium consists of three presentations followed by a faculty discussion.
Note, this on-demand version is not CME accredited.
Key Learning Objectives
- Describe the challenges with lifetime management in severe AS in both a SAVR and TAVI-first scenario
- Summarise clinical evidence for TAVI in low surgical risk patients
- Recall different guideline recommendations for SAVR and TAVI approaches
- Assimilate current clinical knowledge with patient preferences when formulating treatment plans for severe AS patient
- Interventional cardiologists
- Surgeons with an interest in transcatheter treatment strategies for coronary and structural heart disease
- Interventional cardiology nurses
Forward Planning in Severe AS
SAVR vs TAVI in Younger Patients - What do the Clinical Data tell us?
SAVR or TAVI First in Younger Candidates: A Question of Hypotheticals?
Cardiovascular and Thoracic Surgeon
Thomas Modine graduated from Lille University Hospital, France. He has MD, PhD and MBA degrees and is a renowned surgeon in TAVI, TMVR, minimally invasive surgery and valve sparing techniques. He is also involved in basic science research programmes and is developing a percutaneous mitral programme with IP. From 2004 to 2006, Thomas completed a PhD thesis and then went on to complete a 1-and-a-half-year fellowship at Harefield Hospital, London. Later he dedicated his training to the development and progress of percutaneous techniques and heart team approach. His research interests are in aortic valve complex, bioengineering, beating heart surgery, hybrid approaches, TAVI and TMVR. Both basic and clinical aspects of research experiences are studied. He is currently working as a consultant cardiac surgeon at Lille University Hospital and professor at Jiao Tong University, Shanghai.
Dr Modine is an editorial board member of Interventional Cardiology: Reviews,…
Dr David Wood works as an interventional cardiologist at Vancouver General Hospital.
Dr Wood is a professor in the Department of Medicine at the University of British Columbia and a co-founding member of the Centre for Heart Valve Innovation in Vancouver.
He serves as the President of the Canadian Association of Interventional Cardiology.
Victoria Delgado is a cardiologist specializing in non-invasive imaging.
In 2010 she graduated cum laude on the topic “Novel cardiac imaging technologies.” In 2005, she completed training as a cardiologist and in 2006 her interest in non-invasive imaging. Both programs she attended at the Hospital Clinic, associated with the University of Barcelona, Spain.
In 2007 she began a fellowship in “new non-invasive cardiac imaging” at the Cardiology Department at the Leiden University Medical Center. Since 2010 she has been a staff member at the Department of Cardiology of the LUMC
Rebecca T Hahn
Director of Interventional Echocardiography
Rebecca T Hahn is Director of Interventional Echocardiography at NewYork-Presbyterian/ Columbia University Medical Center, US. She also serves as Professor of Clinical Medicine at Columbia College of Physicians and Surgeons. Dr Hahn completed her medical training at University of Washington School of Medicine, and her residency and fellowship at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. Dr Hahn is board certified in cardiovascular disease, internal medicine and echocardiography.